Moreover, mining of public datasets of lymphoma (GSE10846), breast cancer (GSE9893), kidney renal clear cell carcinoma (TCGA) and lung cancer (SurvExpress) revealed that upregulation of SPI1 (p = 4.0 × 10−3, p = 4.5 × 10−5, p = 2.9 × 10−4, p = 3.7 × 10−3), SPIB (p = 4.4 × 10−2, p = 3.1 × 10−5, p = 1.6 × 10−3, p = 5.4 × 10−4), HK2 (p = 3.4 × 10−7, p = 1.7 × 10−2, p = 3.0 × 10−2, p = 2.9 × 10−2) or PGK1 (p = 2.9 × 10−2, p = 3.7 × 10−5, p = 1.7 × 10−4, p = 9.2 × 10−6) was correlated with low survival possibility of patients (Figure S11). This evidence concerns the gene SPIB and breast cancer.